Brainlab HybridArc software for radiosurgery gains US clearance
19 May 2011
Brainlab has received 510(k) clearance from the FDA for its
HybridArc radiosurgery planning solution.
The software increases the efficiency of existing Linac (linear
accelerator) radiosurgery hardware and offers fast, high precision
volumetric arc radiosurgery treatment without the need for costly
hardware upgrades.
HybridArc expands upon the clinically proven and well established
Dynamic Arc stereotactic treatment technique to offer high dose
conformity to the target, while sparing nearby organs and offering
less residual dose when compared to other techniques such as
rotational Intensity Modulated Radiotherapy.
HybridArc uses an adaptive dose calculation matrix that
takes into account the different parameters affecting dose
distribution to provide the necessary precision when opting for
stereotactic radiosurgery.
By using software automation, HybridArc calculates plans
typically within a few minutes. Coupled with reduced treatment
times, more patients can potentially benefit from advanced
radiosurgery. From planning through to patient treatment, HybridArc
ensures clinicians can meet the demands of high dose single fraction
radiosurgery.
Thierry Gevaert, Medical Physicist at Universitair Ziekenhuis,
Brussels, Belgium, who will be using the new system at his
radiosurgery centre comments: “We have looked at HybridArc as a
cost-effective way to expand and improve on the capabilities offered
by our current radiosurgery system. By using HybridArc we can get
the most from our treatment machine, and treat more patients with
precision and speed without having to invest in an expensive new
system.”